Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1185 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

NuPathe receives NoA for Zelrix from USPTO

The patent entitled, ‘Transdermal Methods and Systems for the Delivery of Anti-Migraine Compounds,’ relates to methods of effectively treating a migraine using an iontophoretic patch containing a triptan.

Acura Pharma names interim CEO

Jones has been working with Acura Pharma since April 2008 as the senior vice president and chief operating officer. Jones succeeds Andy Reddick, who passed away on 28

Keryx Q1 net loss widens

Keryx‘s operating loss was $6.48m, compared to $4.1m for the same period in 2010. Other research and development expenses, for the first quarter ended 31 March 2011, increased

MorphoSys group revenues up in Q1

For the first quarter of 2011, the company has reported a net profit of EUR18.8m, or EUR0.81 per diluted share, compared to EUR3.2m, or EUR0.14 per diluted share,

Centocor Ortho cancels trabectedin NDA

Trabectedin is a novel cytotoxic antitumor agent that was originally derived from the marine tunicate, Ecteinascidia turbinata. The company’s decision was based on the US Food and Drug